Congress Materials – European Hematology Association (EHA 2025)
2025 European Hematology Association | Jun 12-15 | Milan, Italy
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
A Systematic Review in Primary and Secondary Warm Autoimmune Haemolytic Anemia: an Outcome-Focused Analysis to Inform the Design of Future Studies
Gonçalo Rodrigues, Ann Leon, Catarina Silva, João Pedro Aguiar, Tom Verbiest, Marie Fitzgibbon, Wim Noel, António Vaz Carneiro
Incidence, prevalence, clinical characteristics, and treatment patterns of patients with warm autoimmune hemolytic anemia: a nationwide population-based study in Taiwan, 2017–2022
Hsiao-Wen Kao, Shu-Chen Chang, Dae Young Yu, I-Ching Tsai, David Bin-Chia Wu, Ann Leon , Concetta Crivera, Alexis Krumme, Tse-Chih Chou, Chee Jen Chang
Increased all-cause mortality among patients diagnosed with warm autoimmune haemolytic anaemia compared to the general population: a nationwide register study in Sweden
Christian Kjellander, Concetta Crivera, Ann Leon, Alexander Litvintchouk, Tina Jacob, Erwei Zeng, Christina Jones, Amy Leval, Tom Verbiest, Wim Noel, Cathye Shu, Gunnar Larfors
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.